The company is in the development phase of an innovative, patented drug for treating nocturia -- frequent urination at night. Currently there are no drugs on the market focused on nocturia, and the company plans to be first to market in the space. Over 100 million people in the US suffer from nocturia. Six patents have currently been issued.

Register now to learn more about this business. Registration is free and takes only a few seconds.

Register Now

Already a DealStream member? .